ML001,Inhibitor of Bacillus stearothermophilus Pyruvate Kinase ,N/A,1,663459,,Bacterial Infections,Kinase,protein,B. sterothermophilus Pyruvate Kinase,,,,,,,,
ML002,Inhibitor of Schistosoma Mansoni Redox Cascade,MH076449-01,1,1756,,Parasitic Diseases ,Oxidoreductase,protein,Schistosoma mansoni peroxiredoxin,,,,,,,,
ML003,Sphingosine-1-phosphate receptor 3 (S1P3) Agonist,MH076449-01,1,2321431,,Cardiovascular diseases,GPCR,protein,S1P3,,,,,,,,
ML004,Sphingosine-1-phosphate receptor 3 (S1P3) Agonist,MH076449-01,1,5309153,,Cardiovascular diseases,GPCR,protein,S1P3,,,,,,,,
ML005,Sphingosine-1-phosphate receptor 3 (S1P3) Agonist,MH076449-01,1,665518,,Cardiovascular diseases,GPCR,protein,S1P3,,,,,,,,
ML006,Sphingosine-1-phosphate receptor 3 (S1P3) Agonist,MH076534-01,1,2842253,,Cardiovascular diseases,GPCR,protein,S1P3,,,,,,,,
ML007,Sphingosine-1-phosphate receptor 1 (S1P1) Agonist,MH076534-01,1,976135,,Cardiovascular diseases,GPCR,protein,S1P1,,,,,,,,
ML008,Glucocerebrosidase Inhibitor (Chemotype 1),MH078932-01,1,5067281,,Nutritional and Metabolic Diseases,Hydrolase,protein,glucocerebrosidase,,,,,,,,
ML009,Glucocerebrosidase Inhibitor (Chemotype 2),MH078932-01,1,2210290,,Nutritional and Metabolic Diseases,Hydrolase,protein,glucocerebrosidase,,,,,,,,
ML010,Glucocerebrosidase Inhibitor (Chemotype 3),MH078932-01,1,17757274,,Nutritional and Metabolic Diseases,Hydrolase,protein,glucocerebrosidase,,,,,,,,
ML011,Molecule Modulators: Voltage-Dependent Potassium (RMI),MH076402-01,1,3194,,Cardiovascular diseases,Ion channel,protein,KvBeta,,,,,,,,
ML012,Allosteric Modulators of the M1 Muscarinic Receptor - Antagonist,MH077606-01,1,3242997,,Nervous System Diseases,GPCR,protein,M1,,,,,,,,
ML013,CREB signaling pathway: CRE potentiator,MH079867-01,1,664279,,Nervous System Diseases,Signalling pathway,GO biological process term,CREB pathway,,,,,,,,
ML014,Rho Kinase II Inhibitor,N/A,1,16681731,,Nervous System Diseases; Neoplasms; Cardiovascular diseases; Nutritional and Metabolic diseases,Kinase,protein,Rho kinase,,,,,,,,
ML015,Zebrafish Angiogenesis Inhibitor,MH077629-01,1,5326739,,Neoplasms ,Biological process,GO biological process term,Angiogenesis,,,,,,,,
ML016,HIV-1 Reverse Transcriptase Associated Ribonuclease H (Rnase H) Inhibitor,MH077605-01,1,665013,,Virus Diseases ,Polymerase,protein,HIV reverse transcriptase,,,,,,,,
ML017,High-Throughput Screening Campaign to Identify Inhibitors of SF-1,MH077624-01,1,4131581,1844, Congenital; Hereditary; and Neonatal Diseases and Abnormalities; Neoplasms,Nuclear receptor,protein,NR5A1,,,,,,,,
ML018,High-Throughput Screening Campaign to Identify Inhibitors of SF-1,MH077624-01,1,23640021,, Congenital; Hereditary; and Neonatal Diseases and Abnormalities; Neoplasms,Nuclear receptor,protein,RAR,,,,,,,,
ML019,High-Throughput Screening Campaign to Identify Inhibitors of SF-1,MH077624-01,1,4076092,1844, Congenital; Hereditary; and Neonatal Diseases and Abnormalities; Neoplasms,Transcription factor,protein,steroidogenic factor 1,,,,,,,,
ML020,Measles Virus Inhibitor,MH080836-01,1,16122506,,Virus Diseases ,Antimicrobial/Antiviral,parasite,Measles virus,,,,,,,,
ML021,Toll-Like Receptor 4-MyD88 Signaling Inhibitor,MH081265-01,1,5716367,1953,Nervous System Diseases,Signalling pathway,protein,TLR4,AAF07823.1,,,,,,,
ML022,12-kDa FK506-binding protein (FKBP12) Activator,MH078942-01,1,16725062,,Immune system diseases,Isomerase,protein,FKBP12,,,,,,,,
ML023,Human Cathepsin L Inhibitor,MH076406-01,1,16725315,,Musculoskeletal system diseases; Immune system diseases; Neoplasms,Protease,protein,Human Cathepsin L,,,,,,,,
ML024,Inhibitors of the NS2B-NS3 Proteinase of West Nile Virus,MH077601-01,1,655490,,Virus Diseases ,Protease,species name,West Nile Virus NS3,,,,,,,,
ML025,AmpC beta-lactamase Covalent Inhibitor,MH079825-01,1,665449,,Bacterial Infections,Hydrolase,protein,AmpC Beta-lactamase,,,,,,,,
ML026,AmpC beta-lactamase Non-Covalent Inhibitor,MH079825-01,1,16752640,,Bacterial Infections,Hydrolase,protein,AmpC Beta-lactamase,,,,,,,,
ML027,High Throughput Screening Campaign to Identify Inhibitors of MMP-8,MH078948-01,1,667639,,Musculoskeletal system diseases,Protease,protein,ADAMTS-4,,,,,,,,
ML028,Tissue-nonspecific Alkaline Phosphatase (TNAP),MH077602-01,1,2931238,,Musculoskeletal system diseases,Phosphatase,protein,Tissue nonspecific alkaline phosphatase (TNAP),,,,,,,,
ML029,Chemical inhibitors of antigen receptor-induced NF-?B,MH077633-01,1,2858522,,Neoplasms ,Signalling pathway,GO biological process term,NF-kappaB pathway,,,,,,,,
ML030,Phosphodiesterase 4 (PDE4) Inhibitor in the cyclic response element-binding proteins (CREB) pathway,MH079867-01,1,17757146,,Nervous System Diseases,Phosphodiesterase,protein,PDE4,,,,,,,,
ML031,Sphingosine-1-phosphate receptor 2 (S1P2) Agonist,MH076534-01,1,2113511,,Cardiovascular diseases,GPCR,protein,S1P2,,,,,,,,
ML032,Matrix Metalloproteinase-13 (MMP-13) Inhibitor,MH078948-01,1,716696,1931,Musculoskeletal system diseases,Protease,protein,MMP-13,,,,,,,,
ML033,Matrix Metalloproteinase-13 (MMP-13) Inhibitor,MH078948-01,1,2047223,1931,Musculoskeletal system diseases,Protease,protein,MMP-13,,,,,,,,
ML034,Matrix Metalloproteinase-8 (MMP-8) Inhibitor,MH078948-01,1,644601,,Musculoskeletal system diseases,Protease,protein,MMP-8,,,,,,,,
ML035,N-(quinolin-8-yl)benzenesulfonamides as Agents Capable of Down-Regulating NF?B Activity within Two Separate High-Throughput Screens of NF?B Activation,MH076344-01,1,16759925,,Neoplasms; Immune System Diseases,Signalling pathway,GO biological process term,NF-kappaB pathway,,,,,,,,
ML036,Human Cathepsin L Inhibitor,MH076406-01,1,23631927,,Immune system diseases,Protease,protein,Human Cathepsin L,,,,,,,,
ML037,Chemical Inhibitors of ER Stress,DA024887-01,1,2878746,,Neurodegeneration,Biological process,GO biological process term,ER stress response,,,,,,,,
ML038,Intestinal alkaline phosphatase (IAP-L) Inhibitor,MH077602-01,1,2946732,,Neoplasms ,Phosphatase,protein,Intestinal alkaline phosphatase,,,,,,,,
ML039,Tissue-nonspecific Alkaline Phosphatase (TNAP),MH077602-01,1,24178170,,Musculoskeletal system diseases,Phosphatase,protein,Tissue nonspecific alkaline phosphatase (TNAP),,,,,,,,
ML040,EphA4 Receptor Antagonists for Nervous System Repair,MH077609-01,1,668744,,Nervous System Diseases,Protein-protein interaction,protein,EphA4,,,,,,,,
ML041,Inhibitor of anti-apoptotic protein Bfl-1,MH077632-01,1,779754,,Neoplasms ,Protein-protein interaction,protein,Bfl-1,,,,,,,,
ML042,Inhibitor of anti-apoptotic protein Bfl-1,MH077632-01,1,2980973,,Neoplasms ,Protein-protein interaction,protein,Bfl-1,,,,,,,,
ML043,Inhibitors of the Polo box domain of Human Polo-like kinase 1 ,MH078944-01,1,5401876,,Neoplasms ,Kinase,protein,Plk-1,,,,,,,,
ML044,Protein Kinase D Inhibitor,DA024898-01 ,1,755673,,Cardiovascular diseases; Neoplasms,Kinase,protein,Protein Kinase D,,,,,,,,
ML045,Aggregation and Clearance of Huntingtin Inclusions: Huntington’s Disease Assay,MH076348-01,1,23631972,,Neurodegeneration,,protein,Huntingtin,,,,,,,,
ML046,Ruthenium-based TrkA Inhibitor,MH077611-01,1,24748038,,Neoplasms; Musculoskeletal Diseases,Kinase,protein,TrkA,,,,,,,,
ML047,Formylpeptide Receptor-Like 1 (FPRL-1) Antagonist,MH076381-01,1,6622773,,Neoplasms; Musculoskeletal Diseases,GPCR,protein,FPRL-1,,,,,,,,
ML048,Formylpeptide Receptor (FPR) Antagonist,MH076381-01,1,3092570,,Neoplasms; Musculoskeletal Diseases,GPCR,protein,FPR,,,,,,,,
ML049,Fluorescent Cross-Reactive FPR/FPRL1 Hexapeptide Ligand,MH076381-01,1,,,Neoplasms; Musculoskeletal Diseases,GPCR,protein,FPRL-1,,,,,,,,
ML050,Competitive inhibitor of lingand binding for G protein-coupled receptor 30 (GPR30),MH077627-01,1,3136844,, Congenital; Hereditary; and Neonatal Diseases and Abnormalities; Neoplasms,GPCR,protein,GPR30,,,,,,,,
ML051,Competitive inhibitor of lingand binding for G protein-coupled receptor 30 (GPR30),MH077627-01,1,5322399,, Congenital; Hereditary; and Neonatal Diseases and Abnormalities; Neoplasms,GPCR,protein,GPR30,,,,,,,,
ML052,Activator of Prostate Cell Differentiation,MH078937-01,1,3240581,,Neoplasms ,Biological process,GO biological process term,Prostate cell differentiation,,,,,,,,
ML053,Autoinducing pheromone (AIP)-dependent bacterial quorum sensing of S. aureus Agr3 agr locus genotype: target downstream of AIP binding,MH078952-01,1,3240990,,Bacterial Infections,Biological process,protein,S. aureus RNAIII,,,,,,,,
ML054,Autoinducing pheromone (AIP)-dependent bacterial quorum sensing:  AIP binding target,MH078952-01,1,2333,,Bacterial Infections,Biological process,protein,S. aureus RNAIII,,,,,,,,
ML055,High Throughput Fluorescence Polarization Screen for Bcl-B Phenotypic Converters ,MH077632-01,1,5816499,,Neoplasms ,Protein-protein interaction,protein,Bcl-B,,,,,,,,
ML056,S1P1 Antagonist,MH076534-01,1,6857802,,Cardiovascular diseases,GPCR,protein,S1P1,,,,,,,,
ML057,Pantothenate Synthetase (PanC) Inhibitor,MH076412-01,1,16750003,,Bacterial Infections,Ligase,protein,M. tuberculosis pantothenate synthase,,,,,,,,
ML058,Inhibitor of the Mevalonate Pathway in Streptococcus pneumoniae 1: Inhibitors of Mevalonate Kinase (MK),MH078936-01,1,16740889,,Bacterial Infections,Kinase,protein,S. pneumoniae Mevalonate Kinase,,,,,,,,
ML059,Tau Filament Binding,MH077621-01,1,663281,,Neurodegeneration,Protein-protein interaction,protein,Tau,,,,,,,,
ML060,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction ,MH077625-01,1,3164059,,Neoplasms; Nervous system diseases,Chaperone,protein,Hsp90,,,,,,,,
ML061,DNA Primase Inihibitor,MH077636-01,1,5281672,,Bacterial Infections,Polymerase,protein,E. coli Pol III HE,,,,,,,,
ML062,DNA-polymerase III (polymerase core enzme) inhibitor,MH077636-01,1,5281855,,Bacterial Infections,Polymerase,protein,E. coli Pol III HE,,,,,,,,
ML063,Ikappa-B-alpha stabilizers in a human lymphoma cell line ,MH078957-01,1,659101,,Immune system diseases,Protein-protein interaction,protein,I-kappa-B-alpha,,,,,,,,
ML064,Epigenetic Modulators,MH079860-01,1,10788,1653,Neoplasms ,Biological process,GO biological process term,Epigenetic regulation,,,,,,,,
ML065,Epigenetic Modulators,MH079860-01,1,975656,1653,Neoplasms ,Biological process,GO biological process term,Epigenetic regulation,,,,,,,,
ML066,Epigenetic Modulators,MH079860-01,1,2876959,1653,Neoplasms ,Biological process,GO biological process term,Epigenetic regulation,,,,,,,,
ML067,Agonists of the Thyroid Stimulating Hormone Receptor,MH080680-01,1,2998659,1401,Nutritional and Metabolic Diseases,GPCR,protein,Thyroid Stimulating Hormone Receptor,,,,,,,,
ML068,Splicing modulators at the Beta Globin locus,MH080684-01,1,2265,1405,Cardiovascular diseases,Transporter,protein,beta-globin,,,,,,,,
ML069,Inhibitors of BRCT-Phosphoprotein Interaction,MH081227-01,1,151582,,Neoplasms ,Chaperone,protein,Hsp90,,,,,,,,
ML070,Tumor Hsp90 Inhibitor,MH076499-01,1,245086,,Neoplasms; Nervous system diseases,Chaperone,protein,Hsp90,,,,,,,,
ML071,Discovery of a Highly Selective in vitro and in vivo M1 Allosteric Agonist Probe,MH077606-01,1,25010775,1798,Nervous System Diseases,GPCR,protein,M1,,,,,,,,
ML072,Probe Report for NPY-Y2 Receptor Antagonists,NS056950-01,1,4460128,1791,Nervous System Diseases,GPCR,peptide,NPY-Y2,,,,,,,,
ML073,Probe Report for NPY-Y2 Receptor Antagonists,NS056950-01,1,3236979,1791,Nervous System Diseases,GPCR,peptide,NPY-Y2,,,,,,,,
ML074,Probe Report for NPY-Y2 Receptor Antagonists,NS056950-01,1,2228302,1791,Nervous System Diseases,GPCR,peptide,NPY-Y2,,,,,,,,
ML075,Probe Report for NPY-Y2 Receptor Antagonists,NS056950-01,1,2936384,1791,Nervous System Diseases,GPCR,peptide,NPY-Y2,,,,,,,,
ML076,Inhibitors of Protein Folding: DnaK,MH078942-01,1,25105719,1501,Bacterial Infections,Chaperone,protein,DnaK,,,,,,,,
ML077,Discovery of a Highly Selective KCC2 Antagonist,NS053658-01,1,25067404,1799,Nervous System Diseases,Ion channel,protein,KCC2,,,,,,,,
ML078,HTS for Inhibitors of BAP1,MH076382-01,1,24178362,,Neoplasms ,protease,protein,Bap1,,,,,,,,
ML079,Identification of Functionally Selective Small Molecule Antagonists of the Neuropeptide-S Receptor: Naphthopyranopyrimidines,DA026210-01,1,3719993,1461,Nervous System Diseases,GPCR,protein,neuropeptide S receptor,,,,,,,,
ML080,Probe Report for P97/cdc48 Inhibitors,MH085687-01,1,25110544,1794,Neurodegeneration,Hydrolase,protein,P97 ATPase,,,,,,,,
ML081,Probe Report for RBBP9 Inhibitors,CA087660-05,1,6603320,1790,Neoplasms ,Hydrolase,protein,RBBP9,,,,,,,,
ML082,Identification of activators for the M2 isoform of human pyruvate kinase,MH085679-01,1,654376,2095,Neoplasms ,Kinase,protein,hPK- M2,,,,,,,,
ML083,Identification of activators for the M2 isoform of human pyruvate kinase,MH085679-01,1,650361,2095,Neoplasms ,Kinase,protein,hPK- M2,,,,,,,,
ML084,Identification of lipid storage modulators,MH085686-01,1,310557,1519,Nutritional and Metabolic Diseases; cardiovascular diseases,Biological process,protein,COPI,,,,,,,,
ML085,Placental Alkaline Phosphatase (PLAP) Luminescent HTS assay,MH077602-01,1,665093,1577,Neoplasms ,Phosphatase,protein,PLAP,,,,,,,,
ML086,The Role of PHOSPHO1 in the Initiation of Skeletal Calcification,MH084086-01,1,16749996,1574,Musculoskeletal system diseases,Phosphatase,protein,PHOSPHO-1,,,,,,,,
ML087,HTS identification of compounds activating TNAP at an intermediate concentration of phosphate acceptor detected in luminescent assay,MH082385-01,1,25199559,1548,Neoplasms ,Phosphatase,protein,TNAP,,,,,,,,
ML088,HTS identification of compounds activating TNAP at an intermediate concentration of phosphate acceptor detected in luminescent assay,MH082385-01,1,704205,1548,Neoplasms ,Phosphatase,protein,TNAP,,,,,,,,
ML089,Therapeutic Inhibitors of Phosphomannose Isomerase,MH082386-01,1,22416235,1545,Nutritional and Metabolic Diseases,Isomerase,protein,PMI,,,,,,,,
ML090,Probe Report for Nox1 Inhibitors,MH083264-01,1,616479,1796,Neoplasms ,Oxidoreductase,protein,Nox1,,,,,,,,
ML091,"Promiscuous and Specific Inhibitors of Cruzain (2-oxo-1,2-diphenylethyl 2-(cyclohexanecarboxamido)acetate)",DA024891-01,1,44143092,"1476, 1478",Parasitic Diseases ,Protease,protein,Cruzain,,,,,,,,
ML092,"Promiscuous and Specific Inhibitors of Cruzain (6-(3,5-difluorophenylamino)-9-ethyl-9H-purine-2-carbonitrile)",DA024891-01,1,44143088,"1476, 1478",Parasitic Diseases ,Protease,protein,Cruzain,,,,,,,,
ML093,Profiling Report: Detergent-sensitive Inhibitors of Cruzain (Aggregators),DA024891-01,0,,"1476, 1478",None,Assay artifacts,N/A,,,,,,,,,
ML094,qHTS Assay for Inhibitors of 15-hLO-1 (15-human lipoxygenase 1),MH081283-01,1,1998940,887,Neoplasms ,Oxidoreductase,protein,15hLO-1,,,,,,,,
ML095,Placental Alkaline Phosphatase (PLAP) Luminescent HTS assay,MH077602-01,1,25067483,1577,Neoplasms ,Phosphatase,protein,PLAP,,,,,,,,
ML096,Therapeutic Inhibitors of Phosphomannose Isomerase,MH082386-01,1,25199533,1545,Nutritional and Metabolic Diseases,Oxidoreductase,protein,PMI,,,,,,,,
ML097,Three small molecule pan activator families of Ras-related GTPases,MH081231-01,1,2160985,1772,Neoplasms ,Hydrolase,protein,cdc42 activated mutant,,,,,,,,
ML098,Three small molecule pan activator families of Ras-related GTPases,MH081231-01,1,7345532,1772,Neoplasms ,Hydrolase,protein,cdc42 activated mutant,,,,,,,,
ML099,Three small molecule pan activator families of Ras-related GTPases,MH081231-01,1,888706,1772,Neoplasms ,Hydrolase,protein,cdc42 activated mutant,,,,,,,,
ML100,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,MH081232-01,1,3380841,1640,Neoplasms ,Biological process,protein,PPC-1 cells + TRAIL,,,,,,,,
ML101,Antagonists of IAP-family anti-apoptotic proteins,MH081277-01,1,25241665,1638,Neoplasms ,Protein-protein interaction,protein,BIR1/2 (XIAP),,,,,,,,
ML102,HTS for Identification of Inhibitors against the ERK Signaling Pathway using a Homogenous Cell-based Assay,MH082406-01,1,2303746,1742,Neoplasms ,GPCR,protein,EGFR,,,,,,,,
ML103,High Throughput Screening for Small Molecule Inhibitors of Heparin-induced Tau Fibril Formation,MH083262-01,1,9795907,1475,Neurodegeneration,Protein-protein interaction,protein,Human tau,,,,,,,,
ML104,High throughput screening for SMA,MH084179-01,1,6404603,1474,Musculoskeletal system diseases,Biological process,GO biological process term,SMN2 protein expression,,,,,,,,
ML105,A high-throughput screen for pre-mRNA splicing modulators,MH084827-01,1,3234998,1997, Congenital; Hereditary; and Neonatal Diseases and Abnormalities,Kinase,protein,Clk4,,,,,,,,
ML106,A high-throughput screen for pre-mRNA splicing modulators,MH084827-01,1,3232621,1997, Congenital; Hereditary; and Neonatal Diseases and Abnormalities,Kinase,protein,Clk4,,,,,,,,
ML107,HTS for inhibitors of Eukaryotic Translation Initiation,MH081216-01,1,16195554,782,Neoplasms ,Protein-protein interaction,protein,eIF4F,,,,,,,,
ML108,Discovery of a Highly Selective in vitro and in vivo M4 Positive Allosteric Modulator (PAM),MH077607-01,1,864492,2616,Nervous System Diseases,GPCR,protein,M4,,,,,,,,
ML109,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,MH080680-01,1,25246343,1401,Nutritional and Metabolic Diseases; cardiovascular diseases,GPCR,protein,TSH receptor,,,,,,,,
ML111,Discovery of a small molecule inhibitor of ROMK and Kir7.1,NS057041-01,1,4536383,2436,Nutritional and Metabolic Diseases,Ion channel,protein,ROMK,,,,,,,,
ML112,Discovery of a small molecule inhibitor of ROMK with unprecedented selectivity,NS057041-01,1,44123657,2436,Nutritional and Metabolic Diseases,Ion channel,protein,ROMK,,,,,,,,
ML113,Small-Molecule Inhibitors of Vaccinia-H1-Related Phosphatase VHR,MH084230-01A1,1,6161281,1661,Neoplasms ,Phosphatase,protein,VHR,,,,,,,,
ML114,Probe Report for RBBP9 Inhibitors,CA087660,1,5934766,1790,Neoplasms ,Hydrolase,protein,RBBP9,,,,,,,,
ML115,Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Activators),MH079826-01,1,6619100,1805,Neoplasms ,Kinase,protein,STAT3,,,,,,,,
ML116,Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Inhibitors),MH079826-01,1,2100018,1806,Neoplasms ,Kinase,protein,STAT3,,,,,,,,
ML117,HTS of TB RmlC & RmlD dTDP-Rhamnose Formation Enzymes,DA024889-01,1,5310786,,Bacterial Infections,,protein,RmlC,,,,,,,,
ML118,Small Molecule Inhibitors of Wee1 Degradation and Mitotic Entry,NS056991-01,1,44552613,1807,Neoplasms ,Kinase,protein,Wee1,,,,,,,,
ML119,HTS for HePTP Inhibitors – a Leukemia Target,MH077603-01,1,1357397,2085,Neoplasms ,Phosphatase,protein,HePTP,,,,,,,,
ML120,HTS for HePTP Inhibitors – a Leukemia Target,MH077603-01,1,4302116,2085,Neoplasms ,Phosphatase,protein,HePTP,,,,,,,,
ML121,HTS Assay for discovery of novel beta-lactamase (BLA) inhibitors via click chemistry,NS059451-01,1,4870494,1854,Bacterial Infections,Hydrolase,protein,VIM-2,,,,,,,,
ML122,Campaign to Identify Agonists of the Transient Receptor Potential Channels 3 and 2 (TRPML3 and TRPML2),MH083077-01,1,701237,1809,Otorhinolaryngologic Diseases,Ion channel,protein,TRPML3,,,,,,,,
ML123,Campaign to Identify Agonists of the Transient Receptor Potential Channels 3 and 2 (TRPML3 and TRPML2),MH083077-01,1,2911646,1809,Otorhinolaryngologic Diseases,Ion channel,protein,TRPML3,,,,,,,,
ML124,Campaign to identify novel modulators of the Retinoic acid receptor-related Orphan Receptors (ROR).,MH084512-01,1,44237404,2139,Nutritional and Metabolic Diseases,Nuclear receptor,protein,ROR-alpha,,,,,,,,
ML125,Campaign to identify novel modulators of the Retinoic acid receptor-related Orphan Receptors (ROR).,MH084512-01,1,447912,2139,Nutritional and Metabolic Diseases,Nuclear receptor,protein,ROR-gamma,,,,,,,,
ML126,Identification of small molecules that selectively inhibit streptokinase expression without suppression of viability in Group A streptococci (probe 1),DA026214-01,1,576989,1677,Bacterial Infections,Biological process,GO biological process term,SK expression,,,,,,,,
ML127,Selective Small Molecule Inhibitors of 12-human lipoxygenase (12hLO),MH081283-01A1,1,44460175,2164,Neoplasms ,Oxidoreductase,protein,12hLO,,,,,,,,
ML128,"Discovery of a potent, selective and in vivo active mGluR4 positive allosteric modulator",NS053536-01,1,44191096,2437,Neurodegeneration,GPCR,protein,mGluR4,,,,,,,,
ML129,"Discovery of the first mAChR 5 (M5) selective ligand, an M5 Positive Allosteric Modulator (PAM)",MH077607-01,1,42633508,2416,Neurodegeneration,GPCR,protein,mAChR 5 (M5),,,,,,,,
ML130,High Throughput Screening Assays for NOD1 Inhibitors (probe 1),MH084844-01,1,1088438,1575,Neoplasms; Immune System Diseases,Signalling pathway,protein,NOD1,,,,,,,,
ML131,Selective Novel Chemical and Immunological Approaches to Influenza Therapy: S1P4 Antagonist,AI074564,1,44607580,1853,Cardiovascular diseases,GPCR,protein,S1P4,,,,,,,,
ML132,A small molecule inhibitor of Caspase 1.,MH078950-01,1,44620939,2389,Neoplasms ,Protease,protein,Caspase 1,,,,,,,,
ML133,A potent and selective small molecule Kir2.1 inhibitor,DA026212-01,1,44247466,1843,Cardiovascular diseases; Nutritional and Metabolic Diseases,Ion channel,protein,Kir2.1,,,,,,,,
ML134,Identification of small molecules that selectively inhibit streptokinase expression without suppression of viability in Group A streptococci (chemotype 2),DA026214-01,1,1612038,1677,Bacterial Infections,Biological process,GO biological process term,SK expression,,,,,,,,
ML135,Identification of small molecules that selectively inhibit streptokinase expression without suppression of viability in Group A streptococci (chemotype 3),DA026214-01,1,2769229,1677,Bacterial Infections,Biological process,GO biological process term,SK expression,,,,,,,,
ML136,Probe Report for PME-1 Inhibitors,CA132630-01,1,44607965,2143,Neoplasms ,Hydrolase,protein,PME-1,,,,,,,,
ML137,Discovery and development of the a highly selective M1 Positive Allosteric Modulator (PAM),MH077606-01,1,44251556,2543,Nervous System Diseases,GPCR,protein,M1,,,,,,,,
ML138,Selective KOP Receptor agonists,DA026208-01,1,44601470,,Nervous System Diseases,GPCR,protein,KOR,,,,,,,,
ML139,Selective KOP Receptor agonists,DA026208-01,1,5236771,1786,Nervous System Diseases,GPCR,protein,KOR,,,,,,,,
ML140,Selective KOP Receptor antagonists,DA026208-01,1,3342390,1785,Nervous System Diseases,GPCR,protein,KOR,,,,,,,,
ML141,A Potent and Selective Inhibitor of Cdc42 GTPase,MH081231-01,1,2950007,1772,Neoplasms ,Protein-protein interaction,protein,Cdc42 wt,,,,,,,,
ML142,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,MH084847-01,1,928277,,Virus Diseases ,Antimicrobial/Antiviral,GO biological process term,Virus induced CPE,,,,,,,,
ML143,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,MH084847-01,1,2557019,1635,Virus Diseases ,Antimicrobial/Antiviral,GO biological process term,Virus induced CPE,,,,,,,,
ML144,Antagonists for the Orphan Receptor GPR35,MH085708-01,1,1542103,,Nervous System Diseases,GPCR,protein,GPR35,,,,,,,,
ML145,Antagonists for the Orphan Receptor GPR35,MH085708-01,1,2286812,2079,Nervous System Diseases,GPCR,protein,GPR35,,,,,,,,
ML146,High Throughput Screening Assays for NOD1 Inhibitors (probe 2),MH084844-01,1,5310346,1575,Neoplasms; Immune System Diseases,Signalling pathway,protein,NOD1,,,,,,,,
ML147,Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandindehydrogenase (HPGD),5U54MH084681 (U54 CDP),1,3245059,,Musculoskeletal system diseases,Oxidoreductase,protein,HPGD,,,,,,,,
ML148,Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandindehydrogenase (HPGD),5U54MH084681 (U54 CDP),1,3243760,,Musculoskeletal system diseases,Oxidoreductase,protein,HPGD,,,,,,,,
ML149,Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandindehydrogenase (HPGD),5U54MH084681 (U54 CDP),1,2331284,2407,Musculoskeletal system diseases,Oxidoreductase,protein,HPGD,,,,,,,,
ML150,Identification of a small molecule that selectively inhibits alpha-synuclein translational expression,NS059434-01,1,1517919,1827,Neurodegeneration,Biological process,GO ID,alpha-synuclein 5'-UTR,,,,,,,,
ML151,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,DK058080,1,5184800,2512,Nutritional and Metabolic Diseases; cardiovascular diseases,GPCR,protein,TR-SRC2,,,,,,,,
ML152,Toward Improved Therapy for Classic Galactosemia,MH085689-01,1,664331,2114,Nutritional and Metabolic Diseases,Kinase,protein,GALK,,,,,,,,
ML154,Identification of Small Molecule Antagonists of the Neuropeptide-S Receptor,DA026210-01,1,46930969,1464,Nervous System Diseases,GPCR,protein,NPSR,,,,,,,,
ML155,Identification of Modulators of the N370S Mutant Form of Glucocerebrosidase as a Potential Therapy for Gaucher Disease (chemotype 1),MH086442-01,1,40225210,2593,Nutritional and Metabolic Diseases,Hydrolase,protein,N370S Glucocerebrosidase,,,,,,,,
ML156,Identification of Modulators of the N370S Mutant Form of Glucocerebrosidase as a Potential Therapy for Gaucher Disease (chemotype 2),MH086442-01,1,9893924,2593,Nutritional and Metabolic Diseases,Hydrolase,protein,N370S Glucocerebrosidase,,,,,,,,
ML157,Identification of Small-Molecule Inhibitors of Trypansoma cruzi Infection-Probe 2,MH085673-01,1,16190867,1885,Parasitic Diseases ,Antimicrobial/Antiviral,GO biological process term,Trypansoma Cruzi replication,,,,,,,,
ML158,Identification of Small-Molecule Inhibitors of Trypansoma cruzi Infection-Probe 3,MH085673-01,1,3238551,1885,Parasitic Diseases ,Antimicrobial/Antiviral,GO biological process term,Trypansoma Cruzi replication,,,,,,,,
ML159,Chemical Genetic Analysis of Platelet Granule Secretion-Probe 1,DA026209-01,1,26871482,1678,Cardiovascular diseases,Biological process,GO biological process term,Granule secretion,,,,,,,,
ML160,Chemical Genetic Analysis of Platelet Granule Secretion-Probe 2,DA026209-01,1,824820,1678,Cardiovascular diseases,Biological process,GO biological process term,Granule secretion,,,,,,,,
ML161,Chemical Genetic Analysis of Platelet Granule Secretion-Probe 3,DA026209-01,1,1048267,1678,Cardiovascular diseases,Biological process,GO biological process term,Granule secretion,,,,,,,,
ML162,Screen for RAS-Selective Lethal Compounds and VDAC Ligands,MH084117-01,1,3689413,1674,Neoplasms ,Biological process,cultured cell name,BJeLR (HRASV12),,,,,,,,
ML163,Identification of a small molecule that selectively activates alpha-synuclein translational expression,NS059434-01,1,1090779,1829,Neurodegeneration,Biological process,GO ID,alpha-synuclein 5'-UTR,,,,,,,,
ML164,Identification of Small-Molecule Inhibitors of Trypansoma cruzi Infection-Probe 1,MH085673-01,1,6875690,1885,Parasitic Diseases ,Antimicrobial/Antiviral,GO biological process term,Trypansoma Cruzi replication,,,,,,,,
ML165,Inhibitors of Platelet Integrin AlphallbBeta3,MH083257-01,1,44820665,2663,Cardiovascular diseases,Receptor,protein,AlphallbBeta3 receptor,,,,,,,,
ML167,Highly specific inhibitors of Clk-4,MH084827-01,1,44968231,1997,Neoplasms ,Kinase,protein,Cdc2-like kinase 4 (Clk4),,,,,,,,
ML168,Identification of compounds which inhibit cytotoxicity associated with the mutant Huntingtin protein expression,MH084839-01A1,1,2432214,1482,Neurodegeneration,Biological process,GO biological process term,Q103HTT induced cytotoxicity,,,,,,,,
ML169,Discovery and development of a second highly selective M1 Positive Allosteric Modulator (PAM).,MH077606-01,1,44475955,2543,Neurodegeneration,GPCR,protein,M1,,,,,,,,
ML170,Identification of activators for the M2 Isoform of human Pyruvate Kinase,MH085679-01,1,4547230,2095,Neoplasms ,Kinase,protein,hPK-M2,,,,,,,,
ML171,Optimization and Characterization of an Inhibitor for NADPH Oxidase 1 (NOX-1),MH083264-01A1,1,81131,1796,Bacterial Infections,oxidase,protein,,NOX1,"179,226,642,538,254,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",271,"7,257,267,277,291,930,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Gary M. Bokoch, The Scripps Research Institute",
ML172,Development of the First Highly Selective mAChR 5 (M5) Positive Allosteric Modulator (PAM),MH077607-01,1,44602489,2416,Nervous System Diseases ,,,,,"6,262,416",540,1700,"Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters","Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Colleen M. Niswender, Vanderbilt University",
ML173,Discovery of a Highly Selective in vitro and in vivo M4 Positive Allosteric Modulator (PAM) Series with Greatly Improved Human Receptor Activity,MH077607-01,1,45142486,2616,Nervous System Diseases ,,,,,"6,256,436,432,616",201,476,"Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters","Vanderbilt Specialized Chemistry Center for Accelerated
Probe Development","Colleen M. Niswender, Vanderbilt University",
ML174,Probe Development Efforts to Identify Novel Inhibitors of Protein Phosphatase Methylesterase-1 (PME-1),CA132630-01,1,24856225,2143,Neoplasms,,,,PPME1,"2,130,217,122,914,630,000,000,000,000",461,1114,The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Benjamin Cravatt, TSRI",
ML175,Optimization and Characterization of an Inhibitor for Glutathione S-Tranferase Omega 1 (GSTO1),CA087660-05,1,4257368,2034,Neoplasms,,,,PPP5C,"1,987,233,123,956,240,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",312,"991,992,193,419,351,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Benjamin Cravatt, TSRI",
ML176,Probe Development efforts to identify novel inverse agonists of the Retinoic acid receptor-related Orphan Receptors (RORs),MH084512,1,2360837,2139,Nutritional and Metabolic Diseases ,,,,,"227,756,161,046,307,000,000,000",483,1303,The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Patrick Griffin, TSRI",
ML177,Small Molecule Inhibitors of Wee1 Degradation and Mitotic Entry,NS056991-01,1,45100431,1807,Neoplasms,,,,,"1,321,141,214,102,080,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",145,"38,313,261,327,199,600,000,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Nagi Ayad, The Scripps Research Institute (TSRI)",
ML178,Probe Development Efforts to Identify Novel Agonists of the Sphingosine 1-phosphate Receptor 4 (S1P4),AI074564,1,44620892,1801,Cardiovascular Diseases ,,,,,"15,091,523,168,625,300,000,000,000,000,000,000,000",314,997,The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Michael B. Oldstone MD, Professor, The Scripps Research Institute",
ML179,Discovery of Inverse Agonists for the Liver receptor homologue-1 (LRH1; NR5A2),MH084512,,45100448,488781,Neoplasms,,,,,,,,,,,
ML180,Discovery of Inverse Agonists for the Liver receptor homologue-1 (LRH1; NR5A2),MH084512,2,3238389,488781,Neoplasms,,,,,"485,348,488,782,488,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",627,"2,400,240,124,022,400,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Patrick Griffin, The Scripps Research Institute (TSRI)",
ML181,Optimization and Characterization of an Antagonist for G-protein Coupled Receptor 7 (GPR7),DA026557-01,1,46172919,1880,Nervous System Diseases ,,,,NPBWR1 ,"1,861,195,222,514,630,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",266,692,The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Olivier Civelli, University of California Irvine",
ML182,"Discovery of a potent, selective and orally active in vivo mGlu4 positive allosteric modulator",NS053536-01,1,46869947,2437,Nervous System Diseases ,,,,,"2,193,219,021,832,190,000,000,000,000,000,000,000,000,000,000,000,000,000,000",541,"17,271,728,172,917,300,000,000,000,000,000,000,000,000,000,000,000,000,000","Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters","Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Colleen M. Niswender, Vanderbilt University",
ML183,Antagonists of IAP-family anti-apoptotic proteins,MH081277-01,1,44176340,1638,Neoplasms,,,,,"4,889,571,638",22,33,Burnham Center for Chemical Genomics,Burnham Center for Chemical Genomics,"John Reed, Burnham Institute for Medical Research",
ML183,Antagonists of IAP-family anti-apoptotic proteins,MH081277-01,1,44176340,1638,Neoplasms ,Protein-protein interaction,protein,BIR1/2 (XIAP),,,,,,,,
ML184,Selective GPR55 Agonists,DA026205-01,,2440433,1965,Substance-Related Disorders ,,,,,,,,Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Mary E. Abood, California Pacific Medical Center Research Institute",
ML185,Selective GPR55 Agonists,DA026205-01,,1374043,1965,Substance-Related Disorders ,,,,,,,,Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Mary E. Abood, California Pacific Medical Center Research Institute",
ML186,Selective GPR55 Agonists,DA026205-01,3,15945391,1965,Substance-Related Disorders ,,,,,"1,961,196,119,652,340,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",253,"603,134,013,421,344,000,000,000,000,000,000,000,000",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Mary E. Abood, California Pacific Medical Center Research Institute",
ML187,Identification of small molecule inhibitors that suppress cytokine-induced apoptosis in human pancreatic islet cells,DK083048,1,46907798,435007,Endocrine System Diseases ,,,,,"435,005,449,756,488,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",510,"1,512,161,616,171,610,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Bridget Wagner, Broad Institute",
ML188,Discovery of non-covalent inhibitors of the SARS main proteinase 3CLpro,MH084162-01A1,1,46897844,1859,Virus diseases,,,,,"1,890,170,618,794,880,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",262,636,The Scripps Research Institute Molecular Libraries Screening Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Andrew Mesecar, Purdue University",
ML189,Identification of small molecules that selectively inhibit fluconazole-resistant Candida albicans in the presence of fluconazole but not in its absence,MH086456-01,1,1251584,2007,Mycoses,,,,,"197,924,674,349,304,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",468,1209,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Susan Lindquist, PhD. Whitehead Institute",
ML190,Antagonist for the Kappa Opioid Receptor,DA026208-01,1,44665680,1785,Nervous System Diseases ,,,,,"17,781,778,228,524,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",257,"6,191,312,136,813,690,000",Sanford-Burnham Center for Chemical Genomics,Kansas Specialized Chemistry Center,"Lawrence Barak, Duke University Medical Center",
ML191,Selective GPR55 Antagonists,DA026205-01,,23612552,2026,Substance-Related Disorders ,,,,,,,,Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Mary E. Abood, California Pacific Medical Center Research Institute",
ML192,Selective GPR55 Antagonists,DA026205-01,,1434953,2026,Substance-Related Disorders ,,,,,,,,Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Mary E. Abood, California Pacific Medical Center Research Institute",
ML193,Selective GPR55 Antagonists,DA026205-01,3,1261822,2026,Substance-Related Disorders ,,,,,"2,013,201,328,202,020,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",263,"6,431,341,134,313,450,000,000,000,000,000",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Mary E.
Abood, California Pacific Medical Center
Research Institute",
ML194,Selective GPR35 Antagonists,MH085708-01,1,9581011,2079,Substance-Related Disorders ,,,,,"2,058,205,823,382,480,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",259,"62,662,762,817,702,200",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Lawrence S. Barak, Duke University Medical Center",
ML198,"Discovery, SAR and Biological evaluation of Pyrazolo[1,5-a]pyrimidines as activators of Glucocerebrosidase with Chaperone Activity.",MH086442-01,1,46907762,2593,Nutritional and Metabolic Diseases ,,,,,"2,101,267,126,712,590,000,000,000,000,000,000,000,000",331,1045,NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Ellen Sidransky, NHGRI",
ML199,Small Molecule Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),MH086444-01,1,46925884,2324,Neoplasms,,,,,"17,052,517,257,225,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",309,"979,980,981,982,190,000,000,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"David M. Wilson III, PhD. NIH, National Institute on Aging",
ML200,Identification of SMN modulators for potential SMA disease therapeutics,MH084179-01,1,46907676,1474,Musculoskeletal Diseases ,,,,,1474,232,"516,872",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Elliot Androphy, University of Massachusetts Medical School",
ML200,Identification of SMN modulators for potential SMA disease therapeutics,MH084179-01,1,46907676,1474,Musculoskeletal system diseases,Biological process,GO biological process term,"SMN2 Protein expression",,,,,,,,
ML201,5-(4-(4-Acetylphenyl)piperazin-1 ylsulfonyl)indolin-2-one Analogs as Inhibitors of Acid alpha-Glucosidase for Potential Chaperone Treatment of Pompe Disease or Intervention for Diabetes Mellitus Type 2,MH084841-01,1,20969430,1473,Endocrine System Diseases ,,,,,"146,622,422,115,211,000,000,000",279,"764,765",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Wei Zheng, NCGC",
ML202,Identification of activators for the M2 isoform of human pyruvate kinase Version 4,MH085679-01,1,44246498,2095,Neoplasms,,,,,"1,631,175,117,511,750,000,000,000,000",289,834,NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Matthew George Vander Heiden, Harvard University",
ML203,Identification of activators for the M2 isoform of human pyruvate kinase Version 3,MH085679-01,1,44543605,2095,Neoplasms,,,,,"1,631,175,117,511,750,000,000,000,000",289,"8,348,358,948,968,980,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Matthew George Vander Heiden, Harvard University",
ML204,Novel Chemical Inhibitor of TRPC4 Channels,NS056942-01,1,230710,2256,"Nervous System Diseases, Cardiovascular Diseases",,,,,"2,247,263,626,374,340,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",208,"48,612,921,297,243,800,000,000",Johns Hopkins Ion Channel Center,"Vanderbilt Specialized Chemistry Center for Accelerated
Probe Development","Michael Zhu, University of Texas",
ML205,Identification of Inhibitors of Trypanosoma brucei Hexokinases,MH082340-01A1,1,46931017,2600,Parasitic diseases,,,,,"1,430,256,016,322,230,000,000,000,000,000,000,000,000",463,"1,144,114,611,481,140",Pittsburgh Screening Center (MLSCN),Kansas Specialized Chemistry Center,"James C. Morris, Clemson University",
ML206,,,,42288156,,,,,,,,,,,,,
ML209,Identification of potent and selective RORgamma antagonists,DA026211-01,1,46943339,2604,Immune System Diseases ,,,,,"25,512,762,489,037,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",234,"5,198,618,628,638,650,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Dan Littman, New York University",
ML210,Screen for RAS-Selective Lethal Compounds and VDAC Ligands,MH084117-01,1,49766530,1674,Neoplasms,,,,,"15,541,936,493,053,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",272,"7,321,150,115,111,520,000,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Brent Stockwell, Columbia University",
ML211,LYPLA1/2 Dual Inhibitor,CA132630-01,1,46937240,2202,Neoplasms,,,,,"217,422,334,931,104,000,000,000",521,"156,518,811,882,263,000,000,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BF Cravatt, TSRI, La Jolla",
ML212,Identification of small molecules that selectively inhibit fluconazole-resistant Candida albicans in the presence of fluconazole but not in its absence—Probe 2,MH086456-01,1,49835877,2007,Mycoses,,,,,"197,924,674,349,304,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",468,1209,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Susan Lindquist, PhD. Whitehead Institute",
ML213,A small molecule activator of KCNQ2 channels,DA027716-01,1,3111211,2258,Cardiovascular Diseases ,,,,,"2,239,228,722,582,280,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",326,"102,211,791,180,118,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",    Johns Hopkins Ion Channel Center,"Vanderbilt Specialized Chemistry Center for Accelerated
Probe Development","Min Li, Johns Hopkins University",
ML214,Discovery of Inhibitors of Anti-apoptotic Protein A1,DA028853-01,1,701939,2526,Neoplasms,,,,,"2462,2765,488858,488858,504345,504345,504347,504347,504413,504413,2526,449754,488898,504344,504403,488934,504365,488948,504354,504346,488897,504359,504392,504360,449755,504343,504348,488885,449761,488902,504353,504405,449757,488891,504342,504409,488914,504356,504407,504412,504415",475,"1,256,125,712,581,250,000,000,000,000,000,000,000,000,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Todd Golub, Broad Institute",
ML216,BLM Helicase Inhibitor,MH087284-01,1,49852229,2386,Neoplasms,,,,,"236,425,282,585,258,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",562,"18,691,873,311,431,100,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Opher Gileadi & Ian Hickson, Structural Genomics Consortium, University of Oxford, UK",
ML217,Cruzain Inhibitor Chemotype #3,DA024891-01,1,3159995,2413,Parasitic diseases,,,,,"21,581,478,493,215,200,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",80,"17,817,915,134,219,400,000,000,000,000,000,000,000",,,,
ML218,Scaffold Hoppings Afford a Highly Selective in vitro and in vivo Calcium T-Type Inhibitor Free from IP Issues,NS050771-01,1,45115620,463087,Nervous System Diseases ,,,,,"449,739,489,005,463,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",204,"4,822,656,265,726,590,000",,,,
ML219,Modulators of Lipid Storage,MH085686-01,,46947845,1623,Nutritional and Metabolic Diseases ,,,,,,,,,,,
ML220,Modulators of Lipid Storage,MH085686-01,3,46947860,1623,Nutritional and Metabolic Diseases ,,,,,"15,192,685,156,915,600,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",301,"936,937,938,229,425,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Dr. Mathias Beller, Max-Planck-Institut für Biophysikalische
Chemie",
ML221,Functional antagonists of the Apelin J (APJ) receptor,NS059422-01,1,7217941,2569,Cardiovascular Diseases ,,,,,"2,521,276,627,844,630,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",520,"156,415,911,995",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Layton H. Smith, Sanford-Burnham Medical Research Institute",
ML223,CBFb-RUNX1 Inhibitor,MH083259-01,1,64983,1484,Neoplasms,,,,,"14,775,043,745,043,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",270,"72,272,417,881,789",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Pu Liu, NHGRI",
ML224,TSH Antagonist,MH090855-01,1,50897809,488990,Endocrine System Diseases ,,,,,"488,980,504,812,488,000,000,000,000,000,000,000,000,000,000,000",607,"225,322,542,257,225,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Marvin Gershengorn, NIDDK",
ML225,PAFAH2 INH,HL084366,1,49837819,492969,Cardiovascular Diseases ,,,,,"492,956,493,030,492,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",568,"19,751,976,197,728,900,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BJ Bahnson, Univ. of DE;  BF Cravatt, TSRI, La Jolla",
ML226,Optimization and characterization of a triazole urea inhibitor for alpha/beta hydrolase domain-containing protein 11 (ABHD11): anti-probe for LYPLA1/LYPLA2 dual inhibitor ML211,CA132630-01,1,46937236,2202/2203 ,Neoplasms,,,,,"217,422,334,931,102,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",521,"156,518,811,882,263,000,000,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BF Cravatt, TSRI, La Jolla",
ML227,Inhibitors of Menin-MLL Interaction,MH084875-01A1,1,46926631,2076,Neoplasms,,,,,"1,768,278,350,453,720,000,000,000,000,000,000,000,000,000,000",260,"629,685,630,631,633",NIH Chemical Genomics Center(NCGC),"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Jolanta Grembecka, Tomasz Cierpicki, UVA",
ML228,Discovery of a small molecule activator of the Hypoxia Inducible Factor Pathway,MH082355-01A2,1,46742353,2437,Neoplasms,,,,,"1,910,208,948,880,540,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",325,"1,016,101,710,181,010",Broad Institute Probe Development Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development",", University of Alabama at Birmingham",
ML229,Identification of small molecules that selectively inhibit fluconazole-resistant Candida albicans in the presence of fluconazole but not in its absence—Probe 3,MH086456-01,1,7694069,2007,Mycoses,,,,,"1979,2467,434930,488836,488836,488907,488930,488943,488943,493080,493080,493089,493089,493081,493081,493150,493150,504502,2007,2327,488809,434923,488911,488933,493099,493147,504525,2423,434935,488909,488807,488905,488950,493064,493082,493069,493149,504504,2400,434938,504390,2388,434945,2387,434946,488893,488802,488937,488932,493070,493134,493157,504499",468,"120,912,101,211,121,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Susan Lindquist, PhD. Whitehead Institute",
ML230,Screening for ABC Transporter Inhibitors,MH081228-01A1,1,44640177,1325,Bacterial Infections,,,,,"1,326,168,916,901,450,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",269,"718,719,720",New Mexico Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"Richard Larson, UNM",
ML231,Chemical Screen of TOR pathway GFP fusion proteins in S. cerevisiae,MH086450-01,1,3392161,1908,Neoplasms,,,,,"1887,1873,1870,1867,1862,2025,2066,2029,2016,2023,2274,2273,2272,2271,2270,2622,2621,2623,2624,2643,2745,2743,2744,2742,2740,488790,488812,488814,504321,488823,488825,488792,488792,488795,488795,488801,488801,488808,488808,488827,488827,504334,504336,504338,504340,504458,504458,504461,504461,504469,504469,504468,504468,504470,504470,1908,2757,488829,488818,504463,504456,504479,504481,504478,504473,504471,504472",332,"10,571,059,106,010,600,000,000,000,000,000",New Mexico Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"Margaret Werner-Washburne, UNM",
ML232,A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV,MH082403-01A1,1,49842897,2440,Virus diseases,,,,,"239,123,914,889,724,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",225,509,,,,
ML233,Functional agonists of the Apelin J (APJ) receptor,NS059422-01,1,46905036,2580,Cardiovascular Diseases ,,,,,"252,027,644,887,484,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",519,"15,631,588",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Layton H. Smith, Sanford-Burnham Medical Research Institute",
ML236,B-cell Specific Inhibitors of NF-?BActivation,MH077633-01,,665654,435012,Neoplasms,,,,,,,,,,,
ML237,B-cell Specific Inhibitors of NF-?BActivation,MH077633-01,2,4174238,435012,Neoplasms,,,,,"435,003,435,020,489,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",544,"1,741,175,117,522,540",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"John C. Reed, Sanford-Burnham Medical Research Institute",
ML238,Inhibitor Components involved in apicoplast function,NS059500-01,1,49849912,488774,Parasitic diseases,,,,,"504,832,624,328,624,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",771,"9,863,572,357,335,740,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),Broad Institute Probe Development Center,"David Fidock, Columbia University",
ML239,High-throughput screening for small molecules with specific toxicity for breast cancer stem cells,MH089663-01,1,49843203,2721,Neoplasms,,,,,"27,174,497,484,931,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",529,1624,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Eric Lander, Broad Institute and Piyush Gupta, Whitehead Institute",
ML240,High-throughput campaign to identify reversible small molecule inhibitor of p97ATPase/Cdc48,MH085687,,49830258,1794,Nervous System Diseases ,,,,,,,,,,,
ML241,High-throughput campaign to identify reversible small molecule inhibitor of p97ATPase/Cdc48,MH085687,2,49830260,1794,Nervous System Diseases ,,,,,"1,481,151,715,341,550,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",251,"593,819,168,916,901,000",,,,
ML242,Discovery and Development of Highly Potent Inhibitors of Mycobacterium tuberculosis Growth In Vitro,MH084877-01A1,1,2792221,449775,Bacterial Infections,,,,,"449762,449762,493198,493198,504556,504556,504646,504646,504646,504897,504897,504857,504857,504903,504903,588447,588447,602435,602435,602435,449775,435019,504335,504562,504684,504854,504909,588445,602431,449764,493181,504564,504645,504860,504898,504901,588437,602437,504642,504682,504853,504910,588441,602432,504640,504683,504852,504911,588443,602433",488,"13,541,356,220,826,500,000",    Southern Research Specialized Biocontainment Screening Center,Kansas Specialized Chemistry Center,"William Bishai, Johns Hopkins",
ML243,High-throughput screening for small molecules with specific toxicity for breast cancer stem cells,MH089663-01,1,50910523,2721,Neoplasms,,,,,"27,174,497,484,931,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",529,1624,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Eric Lander, Broad Institute and Piyush Gupta, Whitehead Institute",
ML244,PPARG partial agonist ,NS061718-01  ,1,53239856,1808,Nutritional and Metabolic Diseases ,,,,,"16,796,311,300,131,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",140,"378,196,119,622,893,000,000,000,000,000,000,000,000",,,,
ML245,High-throughput screening for small molecules with specific toxicity for breast cancer stem cells (Probe 2),MH089663-01,1,50904134,2721,Neoplasms,,,,,"27,174,497,484,931,700,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",529,"1,624,162,516,264,090,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Eric Lander, Broad Institute and Piyush Gupta, Whitehead Institute",
ML246,Discovery and Development of Small Molecules That Reduce PNC Prevalence,MH082371-01,1,50985821,2431,Neoplasms,,,,,"2,417,273,054,036,250,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",291,"8,408,808,818,821,950,000,000,000,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),Kansas Specialized Chemistry Center,"Sui Huang, Northwestern University",
ML247,Alpha- Glucosidase Activator,MH084841-01,1,44246403,1473,Nutritional and Metabolic Diseases ,,,,,"1,466,224,221,152,110,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",279,"764,765,142,114,221,000,000,000,000,000,000,000,000,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),Kansas Specialized Chemistry Center,"Wei Zheng, NHGRI",
ML248,S1P4 Agonist (EC Project),AI074564,1,49835928,1801,Cardiovascular Diseases ,,,,,###############################################################################################################################################################################################################################################################,314,"99,799,819,561,957,100,000,000,000,000,000,000,000,000,000,000,000",NONE,The Scripps Research Institute Molecular Libraries Screening Center,"Michael Oldstone, Scripps",
ML249,: Probe Development Efforts for an Allosteric Agonist of the Sphingosine 1-phosphate Receptor 3 (S1P3),MH076534-01,1,17253208,540309,Cardiovascular Diseases ,,,,,"1,192,373,439,540,340,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",122,"3,513,648,364,936,500,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"M Sanna, Scripps  ",
ML250,GPR7 Antagonist,DA026557-01,1,50904505,1880,Nervous System Diseases ,,,,,"186,119,522,251,463,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",266,"69,269,623,352,795",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Oliver Civelli, University of California Irvine    ",
ML251,Tb PFK Inhibitor,MH092153-01,1,53255421,488768,Bacterial Infections,,,,,"485,368,485,367,492,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",621,"23,622,363,236,423,600,000,000,000,000,000,000,000,000,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Malcom Walkinshaw, University of Edinburgh",
ML252,"Identification of a novel, small molecule inhibitor of KCNQ2 channels",DA027716-01,1,50985951,2262,Cardiovascular Diseases ,,,,,"21,564,930,252,262,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",494,"138,213,831,384,138,000,000,000",    Johns Hopkins Ion Channel Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Min Li, Johns Hopkins University School of Medicine",
ML253,"Extended Probe Characterization: Development of an M4 PAM with Improved Activity and Brain Exposure, while Avoiding Species Bias",MH077607-01,1,53382523,588743,Nervous System Diseases ,,,,,"588,743,623,938,588,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",808,"3,973,397,439,753,970,000,000,000,000","Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Colleen M. Niswender, Vanderbilt University Medical Center",
ML254,Pure Positive Allosteric Modulators (PAMs) of mGlu5 with Competitive MPEP-Site Interaction,MH062646,1,53382545,588721,Nervous System Diseases ,,,,,"588,715,651,835,588,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",770,"3550,3551,3552,3553,3554,3555,3556,3557,3558,3559,3560,",None,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","P. Jeffrey Conn, Vanderbilt University",
ML256,Optimization and characterization of a carbamate inhibitor for plasma plateletactivating factor acetylhydrolase (pPAFAH),HL084366,1,53364507,463092,Cardiovascular Diseases ,,,,,"463,082,463,230,463,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",567,"19,721,973,197,428,900,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BJ Bahnson, Univ. of DE; BF Cravatt, TSRI, La Jolla",
ML257,Probe Development Efforts to Identify Novel Inhibitors of ABHD10,CA132630-01,1,53384746,2143,Neoplasms,,,,,"21,302,171,229,146,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",461,"111,411,151,116,159,000,000,000,000,000,000,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BF Cravatt, TSRI, La Jolla",
ML258,Selective Bcl-2 Inhibitor Probes,MH079850-01,1,53301938,1693,Neoplasms,,,,,"13,241,693",460,"456,457,458,459,460,000,000",New Mexico Molecular Libraries Screening Center,Sanford-Burnham Center for Chemical Genomics,"Larry Sklar, UNM",
ML260,A Selective Murine Intestinal Alkaline Phosphatase (muIAP) Inhibitor,MH077602-01,1,50919367,2818,Nutritional and Metabolic Diseases ,,,,,"28,064,349,714,887,800,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",555,"1,805,183,718,382,460",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Sanford-Burnham Medical Research Institute & José Luis Mils(PI) University of California, Los Angeles, School of Medicine & Jonathan Kaunitz (co-PI)",
ML261,Potent inhibitors of lipid droplet formation,DA026213-01,,9550710,1658,Nutritional and Metabolic Diseases ,,,,,,,,,,,
ML262,Potent inhibitors of lipid droplet formation,DA026213-01,2,20855303,1658,Nutritional and Metabolic Diseases ,,,,,"16,564,631,834,631,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",273,"738,740,741",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Patrick M. McDonough, Ph.D., Vala Sciences, Inc. (San Diego, CA)",
ML264,KLF5 Inhibitor ,DA026215-01,1,51003603,1858,Neoplasms,,,,,"1700,1973,1834,2750,2750,434957,434957,1858,1825,1907,1905,1972,1975,2749,434956,485338,485336,588617,588729,588539,588725,588615,588616,588618,588614,588612,588610,588613,588652,588640,588646,588644,588642,588643,588648,588650,588660,588659,588658,588657,588656,588655,588654,588653,588661,588662,588663,588665,588666,588668,588667,588677",240,"54,979,980,225,452,500,000,000,000,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Vincent Yang, Emory University (now at Stony Brook)",
ML265,"ML265, a potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model.",MH085679-01,1,44246499,602359,Neoplasms,,,,,"1,631,175,125,332,090,000,000,000,000,000,000,000,000,000,000,000,000",289,"8,348,358,948,968,980,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Matt Vander Hedien, MIT",
ML266,Activator of Glucocerebrosidase ,MH086442-01 ,1,46943215,2593,Nutritional and Metabolic Diseases ,,,,,"21,012,671,267,125,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",331,"1,045,104,810,491,050,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),Kansas Specialized Chemistry Center,"Ellen Sidransky, NHGRI, NIH",
ML267,Inhibitor of Sfp-PPTase,MH083266-01,1,53257126,1819,Bacterial Infections,,,,,"14,902,701,270,149,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",221,"505,347,387,034,723,000,000,000,000,000,000,000,000,000,000,000,000,000",,,"Mike Burkart,UCSD",
ML268,TRPML3 AG,MH083077-01,,776924,1809,Nervous System Diseases ,,,,,,,,,,,
ML269,TRPML3 AG,MH083077-01,2,53239838,1809,Nervous System Diseases ,,,,,"14,481,562,142,415,200,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",215,"4,991,328,132,913,300,000",,,,
ML273,Identification of a Selective Allosteric Agonist of mGlu5,MH062646,1,53384845,588721,Nervous System Diseases ,,,,,"588,715,651,835,588,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",770,"3550,3551,3552,3553,3554,3555,3556,3557,3558,3559,3560,",,,,
ML275,A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV,MH082403-01A1,1,5330904,2440,Virus diseases,,,,,"2391,2391,488972,488972,492966,493016,493088,504526,504526,504655,504820,504823,504827,540264,540337,588455,588485,2440,449732,588791,2410,488976,492968,493015,493090,504509,504674,504818,504826,504825,540266,540338,588454,588483,504829,602159,504830,540320,588713",225,"5,091,132,113,311,900,000",,,,
ML276,inhibitor of plasmodium falciparum G6PDH,AI082434-0,1,53362052,504696,Parasitic diseases,,,,,"504,690,504,753,504,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",687,2804,Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Lars Bode, University of California",
ML277,"Discovery of a novel, small molecule activator of the KCNQ1 ion channel",MH090837-01,1,53347902,2699,Cardiovascular Diseases ,,,,,"26,484,930,072,699,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",585,"208,620,872,088,208,000,000,000",Johns Hopkins Ion Channel Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Meng Wu, JHU",
ML278,"Inhibitors of the HDL Receptor, SR-BI",HL052212-11,1,53377439,488952,Cardiovascular Diseases ,,,,,"488,896,493,194,540,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",603,2228,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Monty Krieger, MIT",
ML279,"Inhibitors of the HDL Receptor, SR-BI",HL052212-11,1,53393835,488952,Cardiovascular Diseases ,,,,,"488,896,493,194,540,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",603,2228,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Monty Krieger, MIT",
ML280,STK-33 Probe 1,MH089854-01 ,1,5765514,2689,Neoplasms,,,,,"266,128,215,886,325,000,000,000",512,1529,Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Robert Gould, Broad",
ML281,STK-33 Probe 2,MH089854-01 ,1,53377448,2689,Neoplasms,,,,,"266,128,215,886,325,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",512,"1,529,153,515,361,530",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Robert Gould, Broad",
ML282,"HTS to identify small molecule inhibitors of Ras and Ras-related GTPases, specifically Rab7 wildtype",MH081231-01,1,1067700,1772,Neoplasms,,,,,"76,413,392,051,204,800,000,000",194,"462,463,464,465,466,000",New Mexico Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"Angela Wandinger-Ness, UNM",
ML283,Hepatitis C Virus NS3 Helicase Inhibitor Discovery,MH085690-01,1,14279600,1830,Virus diseases,,,,,"217,318,001,943,247,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",277,"757,758,761,192,050,000,000,000,000,000,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"David Frick, New York Medical College",
ML284,A Cell Based HTS Approach for the Discovery of New Inhibitors of the H5N1 Virus,MH081270-01,1,4397804,2310,Virus diseases,,,,,"7,408,062,310",164,,Southern Research Molecular Libraries Screening Center,Southern Research Molecular Libraries Screening Center,"William Severson, Southern Research Institute",
ML285,ML285 affects reactive oxygen species’ inhibition of pyruvate kinase M2 ,MH085679-01 ,,25210493,602359,Neoplasms,,,,,"602,384,624,391,602,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",831,"4289,4290,4291,4292,4700,",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Matt Vander Hedien, MIT",
ML287,Probe Report for Activators of Small Heterodimer Partner (SHP),MH077624?01,,665747,1954,Cardiovascular Diseases; Endocrine System Diseases ,,,,,,,,,,,
ML288,Probe Report for Activators of Small Heterodimer Partner (SHP),MH077624?01,2,17759818,1954,Cardiovascular Diseases; Endocrine System Diseases ,,,,,"522,692,675",129,,The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Xiaolin Li, PhD, Orphagen Pharmaceuticals",
ML289,Development of the First Selective mGlu3 NAM from an mGlu5 PAM Hit,NS031373,,56587994,602451,Nervous System Diseases ,,,,,"623,885,623,888,623,000,000,000,000,000,000,000,000,000",748,"474,333,333,325",None,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","P. Jeffrey Conn, Vanderbilt University",
ML290,"Discovery, optimization, and biological activity of the first potent and selective smallmolecule agonist series of human relaxin receptor 1 (RXFP1)",MH085705,1,56593349,2703,Female Urogenital Diseases and Pregnancy Complications ,,,,,"26,764,890,124,890,100,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",479,"127,412,771,278,127,000,000,000,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Alexander Agoulnik, Florida International University    ",
ML291,Selective small molecule activator of the apoptotic arm of the UPR,MH089782-01,1,52940465,449771,Neoplasms,,,,,"449,763,463,112,489,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",535,"166,016,633,939,394,000,000,000",Burnham Center for Chemical Genomics,Kansas Specialized Chemistry Center,"Randal J Kaufman, Sanford-Burnham Medical Research Institute (formerly at U. Michigan) & Collaborating PI: Andrew M. Fribley, Wayne State University",
ML292,"Discovery of a novel metabotropic glutamate receptor 4 (mGlu4) positive allosteric modulator (PAM) extended probe: characterization of ML292, a potent and selective mGlu4 PAM which produces efficacy alone or in combination with L-DOPA in preclinical rodent models of Parkinson’s disease",NS053536-01,1,56587900,602453,Nervous System Diseases ,,,,,"623,876,623,875,623,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",821,"4156,4157,4158,4159,4160,4161,4162,4163,4164,4165,4673,",,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Colleen M. Niswender, Vanderbilt University",
ML293,"Discovery of a novel structural class of M4 positive allosteric modulators: characterization of ML293, N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicotinamide, with CNS exposure in rats.",MH077607-01,1,56592940,2616,Nervous System Diseases ,,,,,"625,643,643,261,619,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",201,"476,165,016,511,652,000,000,000,000,000,000,000,000,000,000,000,000",,"Vanderbilt Specialized Chemistry Center for Accelerated
Probe Development","Colleen M. Niswender, Vanderbilt University",
ML294,Optimization and characterization of a triazole urea inhibitor for diacylglycerol lipase beta (DAGL-?),DA025285,1,53364485,504420,Nervous System Diseases ,,,,,"504,411,504,445,504,000",581,2062,The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BF Cravatt, TSRI, La Jolla",
ML295,Optimization and characterization of triazole urea inhibitors for abhydrolase domain containing protein 6 (ABHD6),DA025285,,53364533,504420,Nervous System Diseases ,,,,,,,,,,,
ML296,Optimization and characterization of triazole urea inhibitors for abhydrolase domain containing protein 6 (ABHD6),DA025285,2,53364510,504420,Nervous System Diseases ,,,,,###############################################################################################################################################################################################################################################################,581,"20,622,063,206,445,800,000,000,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"BF Cravatt, TSRI, La Jolla",
ML297,Discovery and Characterization of a Selective Activator of the G-Protein Activated Inward-Rectifying Potassium (GIRK) Channel,MH076398-01,,56642816,463196,Nervous System Diseases ,,,,,"624,435,016,463,196,000,000,000,000,000,000,000,000,000,000,000,000",881,"4,764,476,547,664,760,000,000,000,000","Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","C. David Weaver, Vanderbilt University",
ML298,"Development of a selective, allosteric PLD2 inhibitor",ES013125,,53393915,588854,Neoplasms,,,,,"602,144,602,151,602,000,000,000,000,000,000,000,000,000",796,"3846,3848,3849,3943,4154,",Southern Research Molecular Libraries Screening Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","H. Alex Brown, Vanderbilt University Medical Center",
ML299,"Development of a selective, allosteric PLD1/2 inhibitor in a novel scaffold",ES013125,,56593087,588854,Neoplasms,,,,,"602,144,602,151,602,000,000,000,000,000,000,000,000,000",796,"3846,3848,3849,3943,4154,",Southern Research Molecular Libraries Screening Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","H. Alex Brown, Vanderbilt University Medical Center",
ML300,Non-covalent triazole based inhibitors of the SARS main proteinase 3CLpro,MH084162-01A1,,46861530,1859,Virus diseases,,,,,"18,901,706,187,948,800,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",262,"63,663,719,481,949",The Scripps Research Institute Molecular Libraries Screening Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Andrew Mesecar, Purdue University",
ML301,Small Molecule Agonists for the Neurotensin 1 Receptor (NTR1 Agonists),MH089653-01 ,,49837912,493055,Substance-Related Disorders ,,,,,,,,,,,
ML302,"ML302, a Novel Beta-lactamase (BLA) Inhibitor",NS059451-01 ,,53362017,1854,Bacterial Infections,,,,,"15,271,919,186,021,200,000,000,000,000,000,000,000,000,000,000,000",276,"6,097,496,771,332,130,000,000,000",The Scripps Research Institute Molecular Libraries Screening Center,The Scripps Research Institute Molecular Libraries Screening Center,"Peter Hodder, TSRI",
ML303,Discovery of Small Molecule Influenza Virus NS1 Antagonists,MH085680-01,,53316412,2336,Virus diseases,,,,,"23,264,929,804,929,800,000,000,000,000,000,000,000,000,000,000,000,000,000",286,"82,590,190,232,535,200",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Daniel A. Engel, University of Virginia",
ML304,A 2nd Selective Inhibitor of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase (PfG6PDH): Probe 2,AI082434,1,56639562,504696,Parasitic diseases,,,,,"504,690,504,753,504,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",687,"2,804,280,528,063,500",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Lars Bode, University of California, San Diego and Katja Becker,
Universitat Giessen",
ML306,Discovery of Novel General Anesthetics Using Apoferritin as a Surrogate System,MH084836,,5070704,2385,Wounds and Injuries ,,,,,"23,234,852,814,890,000,000,000,000,000,000,000,000",477,"127,212,765,178",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Roderic G. Eckenhoff, Department of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA",
ML307,Selective UBC 13 Inhibitors,MH085677-01,,56639556,485343,Neoplasms,,,,,"485,273,488,859,493,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",305,"94,924,593,064",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"John C. Reed, M.D., Ph.D. & Sanford-Burnham Medical Research Institute",
ML308,"Development of a Selective Chemical Inhibitor for the Two-Pore Potassium Channel, KCNK9",MH090849-01,,3745727,488964,Neoplasms; Endocrine System Diseases ,,,,,"492,992,488,922,504,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",595,"217,921,802,181,218,000,000,000,000,000,000,000",Johns Hopkins Ion Channel Center,Kansas Specialized Chemistry Center,"Meng Wu, Ph.D., Johns Hopkins University, School of Medicine",
ML309,"ML309, a potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells",DA032129,,56832449,602183,Neoplasms,,,,,"602,179,624,002,624,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",677,"273,727,382,739,274,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Lenny Dang, Agios Pharmaceuticals",
ML310,Identification of a novel selective inverse agonist probe and analogs for the Retinoic acid receptor-related Orphan Receptor Gamma (ROR?),MH084512,,51035449,2139,Nutritional and Metabolic Diseases ,,,,,"2,277,561,610,463,070,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",483,"130,313,041,305,155,000,000,000,000,000,000,000",The Scripps Research Institute,The Scripps Research Institute Molecular Libraries Screening Center,"Patrick Griffin, The Scripps Research Institute (TSRI)",
ML311,"ML311, A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: a Probe for Studying Lymphoid Tumorigenesis",CA135915-01,,3384730,2090,Neoplasms,,,,,"205,721,682,217,493,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",310,"9,839,841,603,160,410,000,000",The Scripps Research Institute,The Scripps Research Institute Molecular Libraries Screening Center,"Michael Cardone, Eutropics Pharmaceuticals",
ML312,A Small Molecule Inhibitor of Scavenger Receptor BI-mediated Lipid Uptake—Probe 3,HL052212-11,,44487061,488952,Cardiovascular Diseases ,,,,,"488896,493194,540354,540354,588392,588392,588553,588553,588548,588548,588754,588754,588828,588828,588833,588833,602285,623880,623880,624029,624029,488952,540246,588842,588830,588829,588826,602126,623895,624026,588777,588810,624024,602134,588818,602152,624017,540326,588403,588825,624007,602154,624010,588831,624022,588836,624015,588843,602138,588837,602155",603,"222,822,292,230,223,000,000,000,000,000,000,000,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Monty Krieger, Biology Department, Massachusetts Institute of Technology",
ML314,Small Molecule Agonists for the Neurotensin 1 Receptor (NTR1 Agonists),MH089653-01 ,2,53245590,493055,Substance-Related Disorders ,,,,,"493,036,504,550,504,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",530,"163,316,381,639,294,000,000,000",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Lawrence R. Barak, Duke University Medical Center, Durham NC",
ML315,"Identification of selective inhibitors of cdc2-like kinases 1 and 4 (Clk1, Clk4).",MH084827,,46926514,1997,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities ",,,,,"1,795,198,319,831,990,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",500,"520,142,814,311,432,000,000,000,000",NIH Chemical Genomics Center(NCGC),Kansas Specialized Chemistry Center,"Tom Misteli, National Cancer Institute",
ML316,Probing Metabolic Requirements for Fungal Virulence — Probe 1,MH086456-01,,56604860,588528,Mycoses,,,,,"588529,588529,602190,602190,602189,602189,588530,588530,623899,623899,623897,623897,623981,623981,624006,624006,623982,623982,588528,588634,602188,602394,602184,623969,624012,602187,623971,624025,602186,623903,623965,624014,602185,623904,623967,624013,624062,624068",784,"37,223,723,372,437,200,000,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Susan Lindquist, PhD, Whitehead Institute, Cambridge, MA",
ML317,"3-[(2,6-difluorobenzoyl)amino]-5-(4-ethoxyphenyl)thiophene-2-carboxylic acid inhibits E.coli UT189 bacterial capsule biogenesis.",MH090791 ,,18109210,488970,Bacterial Infections,,,,,"488,966,488,966,602,000,000,000,000,000",589,2114,Southern Research Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"Patrick Seed, Duke University",
ML318,"Identification of a small molecule inhibitor of Pseudomonas aeruginosa PvdQ acylase, an enzyme involved in siderophore pyoverdine synthesis",MH092076,,56604881,488968,Bacterial Infections,,,,,###############################################################################################################################################################################################################################################################,631,"242,824,292,431",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Dr. Andrew Gulick, Hauptman-Woodward Medical Research Institute, State University of New York, Buffalo, NY",
ML320,Discovery of Potent and Highly Selective Inhibitors of GSK3b,MH087442,,56840716,2119,Nervous System Diseases ,,,,,"20,974,349,546,239,800,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",474,"124,712,481,249,125,000,000,000,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Jen Pan, Stephen Haggarty, Broad Institute, Stanley Center",
ML321,"Discovery, optimization, and characterization of a novel series of dopamine D2 versus D3 receptor selective antagonists",NS064831,,57377246,485359,Immune System Diseases ,,,,,"485,344,624,453,624,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",591,"2,139,516,351,645,160,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"David Sibley, NINDS",
ML322,"ML322, A Small Molecule Inhibitor of Dimerization of the Core Protein of Hepatitis C Virus (HCV)",MH085709-01 ,,49800087,1911,Virus diseases,,,,,"2,159,189,924,881,910,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",261,"6,341,596,224,422,450,000",The Scripps Research Institute,The Scripps Research Institute,"Arthur Strosberg, Scripps Research Institute",
ML323,Discovery of ML323 as a Novel Inhibitor of the USP1/UAF1 Deubiquitinase Complex,DA030552,,60167849,504878,Neoplasms,,,,,"504,865,540,327,651,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",609,"2,276,227,822,794,910,000,000,000,000",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Zhihao Zhuang, University of Delaware",
ML324,"Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity",MH084681,,44143209,2421,Virus diseases,,,,,"2,147,267,726,772,670,000,000,000,000,000,000",552,"178,517,861,787",NIH Chemical Genomics Center(NCGC),NIH Chemical Genomics Center(NCGC),"Udo Oppermann, Structural Genomics Consortium, University of Oxford",
ML325,Optimization and characterization of a pan protein arginine deiminase (PAD) inhibitor,GM079357-01,,13891339,463083,Immune System Diseases ,,,,,"463,073,485,272,488,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",484,"13,072,547,392,239,200,000,000,000,000,000",The Scripps Research Institute,The Scripps Research Institute,"Paul R. Thompson, The Scripps Research Institute, Jupiter, FL",
ML326,Development and characterization of a highly selective M5 PAM probe molecule  with improved potency,MH077607,,57525860,2416,Nervous System Diseases ,,,,AAF07823.1,"62,624,162,204,219,400,000,000,000,000,000,000",540,"17,001,701,170,217,000,000,000,000,000,000",The Scripps Research Institute,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Colleen M. Niswender, Vanderbilt University",
ML327,Discovery and characterization of a small molecule that restores E-cadherin expression in cancer cell lines via a new mechanism,CA95103-09,,60167648,651824,Neoplasms,,,,,651862,883,4784,,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","R. Daniel Beauchamp, Vanderbilt University",
ML328,"ML328, A Novel Dual Inhibitor of Bacterial AddAB and RecBCD Helicasenuclease DNA Repair Enzymes",GM031693 ,,1517823,449731,Bacterial Infections,,,,,"435,030,488,942,492,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",564,"1,903,190,419,054,190,000,000,000,000",The Scripps Research Institute,The Scripps Research Institute,"G. Smith, Fred Hutchinson Cancer Research Center",
ML329,A Small Molecule Inhibitor of the MITF Molecular Pathway,DA031089-01,,12387471,488944,Neoplasms,,,,,"540,258,588,334,624,000,000,000,000,000,000,000,000,000,000,000",721,"234,331,023,103",Broad Institute Probe Development Center,Kansas Specialized Chemistry Center,"David E. Fisher, Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School",
ML330,Cardioprotective inhibitors of reperfusion injury,DA031671-01,,60202221,588508,Cardiovascular Diseases ,,,,,,,,,,,
ML331,Cardioprotective inhibitors of reperfusion injury,DA031671-01,2,60202247,588508,Cardiovascular Diseases ,,,,,"588,492,588,779,623,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",673,"2,721,272,227,232,720",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Richard Kitsis, Albert Einstein College of Medicine of Yeshiva University, USA",
ML332,Identification of a glycine sulfonamide based non-MPEP site positive allosteric potentiator (PAM) of mGlu5,MH062646,,60210882,588721,Nervous System Diseases ,,,,,"588,715,651,835,588,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",770,"3550,3551,3552,3553,3554,3555,3556,3557,3558,3559,3560,",,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","P. Jeffrey Conn, Vanderbilt University",
ML333,N-(pyridin-4-yl)benzo[d]thiazole-6-carboxamide inhibits E. coli UT189 bacterial capsule biogenesis,MH090791-01,,18109210,488970,Bacterial Infections,,,,,"488,966,488,966,602,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",589,"211,421,252,126,212,000,000,000",Southern Research Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"Patrick Seed, Duke University",
ML334,The identification and characterization of non-reactive inhibitor of Keap1-Nrf2 interaction through HTS using a fluorescence polarization assay,MH093197,,56840728,504540,Neoplasms,,,,,"504,523,588,683,651,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",689,"28,142,816,281,728,100,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"LONGQIN HU , Rutgers",
ML335,Characterization of an agonist probe for opioid receptor mu 1 (OPRM1)-opioid receptor delta 1 (OPRD1) heterodimerization,NS053751-01,,23723457,504355,Nervous System Diseases ,,,,,"504,326,504,357,504,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",142,"3,802,282,228,322,840,000",The Scripps Research Institute,The Scripps Research Institute,"Laksmi Devi, Mount Sinai School Of Medicine",
ML336,ML336: Development of Quinazolinone-Based Inhibitors Against Venezuelan Equine Encephalitis Virus (VEEV),MH087448-01A1,,60156253,588723,Virus diseases,,,,,###############################################################################################################################################################################################################################################################,670,"2,699,270,027,012,700,000,000,000,000",Southern Research Molecular Libraries Screening Center,Kansas Specialized Chemistry Center,"Dr. Donghoon Chung, University of Louisville",
ML337,Development of A Second Generation Selective mGlu3 NAM Probe,NS031373,,60204017,612451,Nervous System Diseases ,,,,,"623,885,651,839,623,000,000,000",748,"332,533,334,743",,"Vanderbilt Specialized Chemistry Center for Accelerated
Probe Development","P. Jeffrey Conn, Vanderbilt University",
ML338,"Elucidation of the physiology of non-replicating, drug tolerant Mycobacterium tuberculosis with the aid of the small molecule probe ML338",MH07444-01,,60182306,488929,Bacterial Infections,,,,,"488,890,488,890,488,000,000,000,000,000,000,000,000,000,000,000,000,000",742,"129,032,743,275,327,000,000,000",Southern Research Molecular Libraries Screening Center,Broad Institute Probe Development Center,"Deborah T. Hung, PhD, Broad Institute of MIT and Harvard, Cambridge, MA.",
ML339,Probing the CXCR6/CXCL16 Axis: Targeting Prevention of Prostate Cancer Metastasis,MH095589,,60202254,602249,Neoplasms,,,,,"602,244,602,409,624,000,000,000,000,000,000,000,000,000,000,000",800,"38,713,872,387,438,700,000",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"Gregory P. Roth, Ph.D., Sanford-Burnham Medical Research Institute Russell S.Taichman, Ph.D., University of Michigan",
ML340,Small-molecule antagonists of Gli function,MH094195-01,,65389180,588433,Neoplasms,,,,,"588,413,602,428,602,000,000,000,000,000,000,000",725,"314,331,443,146",Sanford-Burnham Center for Chemical Genomics,Sanford-Burnham Center for Chemical Genomics,"James K. Chen, Ph.D., Stanford University, Stanford, CA, USA.",
ML341,"Identification of Diversity-Oriented Synthesis Derived Small Molecule, ML341, with Cidal Activity Against Trypanosoma cruzi",MH085673-01,,44493436,624280,Parasitic diseases,,,,,"6,242,556,517,396,510,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",730,"31,773,178,318,153,600,000,000,000,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Ana Rodriguez, PhD., New York University",
ML342,Inhibitors of FAP-fluorogen interaction as a multiplex assay tool compound for receptor internalization assays,DA031668-01,,2953239,651701,None,,,,,"588,775,623,882,623,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",906,"5036,5037,5038,5039,5040,5041,",New Mexico Molecular Libraries Screening Center,"Vanderbilt Specialized Chemistry Center for Accelerated Probe Development","Jonathan Jarvik, Carnegie Mellon University",
ML343,"Discovery of Two, Structurally Distinct Agonists of Vibrio cholerae Quorum Sensing Acting via the CqsS Membrane Receptor",MH094166-01,,57525036,,Bacterial Infections,,,,,,,,,,,
ML344,"Discovery of Two, Structurally Distinct Agonists of Vibrio cholerae Quorum Sensing Acting via the CqsS Membrane Receptor",MH094166-01,2,4727493,588521,Bacterial Infections,,,,,"588,436,602,243,588,000,000,000,000,000,000,000,000,000,000,000",734,"31,943,202,320,832,000,000",Broad Institute Probe Development Center,Broad Institute Probe Development Center,"Bonnie L. Bassler, PhD., Princeton University, Princeton, NJ",
ML345,"ML345, A Small-Molecule Inhibitor of the Insulin-Degrading Enzyme (IDE)",DA024888-01,,57390068,434984,Endocrine System Diseases ,,,,,"434,962,435,028,463,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000",299,"93,293,326,782,679,200,000,000,000",The Scripps Research Institute,The Scripps Research Institute,"Malcolm Leissring, Scripps",
ML346,"ML346, A Novel Modulator of Proteostasis for Protein Conformational Diseases,1029,1618,1643",NS056337-02,,767276,588815,Nervous System Diseases ,,,,,"1259,651945,651948,651964,651992,651963,",936,"542,154,225,423,542,000,000,000",The Scripps Research Institute,The Scripps Research Institute,"R. Morimoto, Northwestern University",
